NEW YORK – Lawmakers in the Netherlands are advancing a plan to make whole-genome sequencing (WGS) the standard of care for advanced cancer patients in the country. Get the full story with Premium Access Only $95 for the first 90 days* Premium Access gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives Never miss another important industry story. Try Premium Access...